Is 45 years-of-age the cut-off for using autologous oocytes?
A case report published in this issue of RBMO (Gleicher et al., 2018) invites a philosophical debate around two women, both aged 47 years, who became pregnant from autologous oocytes, one progressing to a pre-term livebirth at 35 weeks, by which time the mother was 48 years old. Each woman received...
| Autors principals: | , , , |
|---|---|
| Format: | Journal article |
| Publicat: |
Elsevier
2018
|
| _version_ | 1826281425635115008 |
|---|---|
| author | Yovich, J Chapman, M Keane, K Savulescu, J |
| author_facet | Yovich, J Chapman, M Keane, K Savulescu, J |
| author_sort | Yovich, J |
| collection | OXFORD |
| description | A case report published in this issue of RBMO (Gleicher et al., 2018) invites a philosophical debate around two women, both aged 47 years, who became pregnant from autologous oocytes, one progressing to a pre-term livebirth at 35 weeks, by which time the mother was 48 years old. Each woman received adjuvants, either dehydroepiandrosterone (DHEA) or growth hormone (GH). The case report also notes two further livebirths in 2016 in women aged 45 years. |
| first_indexed | 2024-03-07T00:28:37Z |
| format | Journal article |
| id | oxford-uuid:7efe81af-fd5e-4b4a-9145-f65891f7a0f1 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T00:28:37Z |
| publishDate | 2018 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:7efe81af-fd5e-4b4a-9145-f65891f7a0f12022-03-26T21:13:54ZIs 45 years-of-age the cut-off for using autologous oocytes?Journal articlehttp://purl.org/coar/resource_type/c_b239uuid:7efe81af-fd5e-4b4a-9145-f65891f7a0f1Symplectic Elements at OxfordElsevier2018Yovich, JChapman, MKeane, KSavulescu, JA case report published in this issue of RBMO (Gleicher et al., 2018) invites a philosophical debate around two women, both aged 47 years, who became pregnant from autologous oocytes, one progressing to a pre-term livebirth at 35 weeks, by which time the mother was 48 years old. Each woman received adjuvants, either dehydroepiandrosterone (DHEA) or growth hormone (GH). The case report also notes two further livebirths in 2016 in women aged 45 years. |
| spellingShingle | Yovich, J Chapman, M Keane, K Savulescu, J Is 45 years-of-age the cut-off for using autologous oocytes? |
| title | Is 45 years-of-age the cut-off for using autologous oocytes? |
| title_full | Is 45 years-of-age the cut-off for using autologous oocytes? |
| title_fullStr | Is 45 years-of-age the cut-off for using autologous oocytes? |
| title_full_unstemmed | Is 45 years-of-age the cut-off for using autologous oocytes? |
| title_short | Is 45 years-of-age the cut-off for using autologous oocytes? |
| title_sort | is 45 years of age the cut off for using autologous oocytes |
| work_keys_str_mv | AT yovichj is45yearsofagethecutoffforusingautologousoocytes AT chapmanm is45yearsofagethecutoffforusingautologousoocytes AT keanek is45yearsofagethecutoffforusingautologousoocytes AT savulescuj is45yearsofagethecutoffforusingautologousoocytes |